Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
XLRM Stock Summary
In the News
XLRM Financial details
Company Rating
-
Market Cap
0
Income
-1.65M
Revenue
2.16M
Book val./share
-0.12
Cash/share
0.07
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
-5.78
Forward P/E
-
PEG
0.47
P/S
-
P/B
-0.85
P/C
14.29
P/FCF
-
Quick Ratio
0.01
Current Ratio
0.01
Debt / Equity
-1.79
LT Debt / Equity
-0.3
-
-
EPS (TTM)
-0.3
EPS next Y
-
EPS next Q
-
EPS this Y
-116.03%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
178.37%
-
-
-
-
SMA20
-1.94%
SMA50
-29.37%
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-1036%
ROE
16%
ROC
0.13%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
12.66M
Shs Float
662.1K
-
-
-
-
Target Price
-
52W Range
1.23-1.4
52W High
0%
52W Low
0%
RSI
34.12
Rel Volume
3.12
Avg Volume
1.64K
Volume
5.1K
Perf Week
-0.99%
Perf Month
-1.96%
Perf Quarter
-
Perf Half Y
-27.01%
-
-
-
-
Beta
-7.68859
-
-
Volatility
0%, 0.03%
Prev Close
0%
Price
1
Change
0%
XLRM Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2007-01-31
Metric | History | 2003-06-30 | 2004-06-30 | 2006-01-31 | 2007-01-31 |
---|---|---|---|---|---|
2K | 2K | 2.01K | 2.01K | ||
Revenue per share | 0 | 0 | 0 | 0 | |
Net income per share | -0.04 | -0.01 | 1.31 | -0.21 | |
Operating cash flow per share | -0.03 | -0.38 | -0.17 | -0.05 | |
Free cash flow per share | -0.03 | -0.38 | -0.17 | -0.05 | |
Cash per share | 0 | 0 | 0.01 | 0.02 | |
Book value per share | -0.01 | 0.41 | -1.2 | -1.46 | |
Tangible book value per share | -0.01 | 0.41 | -1.2 | -1.46 | |
Share holders equity per share | -0.01 | 0.41 | -1.2 | -1.46 | |
Interest debt per share | 0 | 0 | 0.81 | 0.8 | |
Market cap | 1.78M | 1.8M | 639.85K | 624.84K | |
Enterprise value | 1.77M | 1.8M | 1M | 1.01M | |
P/E ratio | -28.07 | -200.8 | 0.94 | -5.78 | |
Price to sales ratio | 0 | 0 | 0 | 0 | |
POCF ratio | -35.37 | -3.21 | -7.14 | -26.66 | |
PFCF ratio | -35.37 | -3.21 | -7.14 | -26.66 | |
P/B Ratio | -144.95 | 2.99 | -1.02 | -0.85 | |
PTB ratio | -144.95 | 2.99 | -1.02 | -0.85 | |
EV to sales | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | -28.06 | -200.8 | 1.35 | -10.15 | |
EV to operating cash flow | -35.36 | -3.21 | -11.16 | -43.15 | |
EV to free cash flow | -35.36 | -3.21 | -11.16 | -43.15 | |
Earnings yield | -0.04 | 0 | 1.06 | -0.17 | |
Free cash flow yield | -0.03 | -0.31 | -0.14 | -0.04 | |
Debt to equity | 0 | 0 | -0.59 | -0.54 | |
Debt to assets | 0 | 0 | 69.28 | 38.01 | |
Net debt to EBITDA | 0.01 | 0 | 0.49 | -3.88 | |
Current ratio | 0.07 | 0 | 0.01 | 0.01 | |
Interest coverage | 0 | 0 | -3.14 | -11.65 | |
Income quality | 0.79 | 0.25 | -0.13 | 0.22 | |
Dividend Yield | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | |
Graham number | 0.09 | 0.24 | 5.95 | 2.64 | |
ROIC | 5.16 | -0.01 | 0.64 | 0 | |
Return on tangible assets | -74.05 | -0.01 | 128.95 | -10.36 | |
Graham Net | -0.01 | -0.01 | -1.2 | -1.46 | |
Working capital | -12.25K | -21.24K | -625.19K | -739.35K | |
Tangible asset value | -12.25K | 603.76K | -625.19K | -739.35K | |
Net current asset value | -12.25K | -21.24K | -625.19K | -739.35K | |
Invested capital | 0 | 0 | -0.59 | -0.54 | |
Average receivables | 0 | 0 | 0 | 0 | |
Average payables | 0 | 4.75K | 34.04K | 75.82K | |
Average inventory | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | |
Days payables outstanding | 1.44K | 1.22K | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | |
Payables turnover | 0.25 | 0.3 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | |
ROE | 5.16 | -0.01 | -1.09 | 0.15 | |
Capex per share | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2021-03-31 for Q1
Metric | History | 2006-04-30 | 2006-07-31 | 2006-10-31 | 2007-01-31 | 2021-03-31 |
---|---|---|---|---|---|---|
2.01K | 2.01K | 2.01K | 2.01K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0.17 | |
Net income per share | -0.05 | -0.07 | -0.05 | -0.05 | -0.13 | |
Operating cash flow per share | -0.02 | -0.01 | -0.02 | 0 | 0.01 | |
Free cash flow per share | -0.02 | -0.01 | -0.02 | 0 | 0 | |
Cash per share | 0.01 | 0 | 0 | 0.02 | 0.07 | |
Book value per share | -1.28 | -1.36 | -1.41 | -1.46 | -0.12 | |
Tangible book value per share | -1.28 | -1.36 | -1.41 | -1.46 | -0.14 | |
Share holders equity per share | -1.28 | -1.36 | -1.41 | -1.46 | -0.12 | |
Interest debt per share | 0.73 | 0.75 | 0.77 | 0.79 | 0.21 | |
Market cap | 624.84K | 624.84K | 624.84K | 624.84K | 15.39M | |
Enterprise value | 990.33K | 1M | 1.01M | 1.01M | 17.15M | |
P/E ratio | -6.59 | -4.47 | -6.06 | -6.58 | -2.45 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 7.12 | |
POCF ratio | -74.63 | -115.67 | -68.1 | -1.28K | 184.76 | |
PFCF ratio | -74.63 | -115.67 | -68.1 | -1.28K | 386.87 | |
P/B Ratio | -0.96 | -0.91 | -0.87 | -0.85 | -10.44 | |
PTB ratio | -0.96 | -0.91 | -0.87 | -0.85 | -10.44 | |
EV to sales | 0 | 0 | 0 | 0 | 7.93 | |
Enterprise value over EBITDA | -45.96 | -30.51 | -42.79 | -46.8 | -11.89 | |
EV to operating cash flow | -118.29 | -185.44 | -110.18 | -2.06K | 205.8 | |
EV to free cash flow | -118.29 | -185.44 | -110.18 | -2.06K | 430.91 | |
Earnings yield | -0.04 | -0.06 | -0.04 | -0.04 | -0.1 | |
Free cash flow yield | -0.01 | -0.01 | -0.01 | 0 | 0 | |
Debt to equity | -0.57 | -0.55 | -0.54 | -0.54 | -1.79 | |
Debt to assets | 67.32 | 3.46K | 414.35 | 38.01 | 0.67 | |
Net debt to EBITDA | -16.96 | -11.48 | -16.34 | -17.89 | -1.22 | |
Current ratio | 0.01 | 0 | 0 | 0.01 | 0.26 | |
Interest coverage | -10.08 | -15.36 | -11.06 | -10.11 | -1.5 | |
Income quality | 0.35 | 0.15 | 0.36 | 0.02 | -0.05 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0.46 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0.08 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | -0.52 | |
Capex to revenue | 0 | 0 | 0 | 0 | -0.02 | |
Capex to depreciation | 0 | 0 | 0 | 0 | -0.45 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 1.16 | 1.45 | 1.27 | 1.24 | 0.58 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | -4.3 | -320.8 | -27.58 | -2.27 | -0.43 | |
Graham Net | -1.28 | -1.36 | -1.41 | -1.46 | -0.35 | |
Working capital | -648.87K | -689.84K | -715.61K | -739.35K | -3.71M | |
Tangible asset value | -648.87K | -689.84K | -715.61K | -739.35K | -1.77M | |
Net current asset value | -648.87K | -689.84K | -715.61K | -739.35K | -4.16M | |
Invested capital | -0.57 | -0.55 | -0.54 | -0.54 | -1.79 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 64.25K | 70.19K | 78.68K | 82.14K | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 4.32 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 155.77 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 22.3 | |
Receivables turnover | 0 | 0 | 0 | 0 | 20.85 | |
Payables turnover | 0 | 0 | 0 | 0 | 0.58 | |
Inventory turnover | 0 | 0 | 0 | 0 | 4.04 | |
ROE | 0.04 | 0.05 | 0.04 | 0.03 | 1.06 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
XLRM Frequently Asked Questions
What is XLR Medical Corp. stock symbol ?
XLR Medical Corp. is a US stock , located in Long beach of Ny and trading under the symbol XLRM
What is XLR Medical Corp. stock quote today ?
XLR Medical Corp. stock price is $1 today.
Is XLR Medical Corp. stock public?
Yes, XLR Medical Corp. is a publicly traded company.